AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.

Autor: Bansal A; Institute of Protein Biochemistry, Ulm University, Ulm, Germany., Schmidt M; Institute of Protein Biochemistry, Ulm University, Ulm, Germany., Rennegarbe M; Institute of Protein Biochemistry, Ulm University, Ulm, Germany., Haupt C; Institute of Protein Biochemistry, Ulm University, Ulm, Germany., Liberta F; Institute of Protein Biochemistry, Ulm University, Ulm, Germany., Stecher S; Institute of Protein Biochemistry, Ulm University, Ulm, Germany., Puscalau-Girtu I; Institute of Protein Biochemistry, Ulm University, Ulm, Germany., Biedermann A; Institute of Protein Biochemistry, Ulm University, Ulm, Germany., Fändrich M; Institute of Protein Biochemistry, Ulm University, Ulm, Germany. marcus.faendrich@uni-ulm.de.
Jazyk: angličtina
Zdroj: Nature communications [Nat Commun] 2021 Feb 12; Vol. 12 (1), pp. 1013. Date of Electronic Publication: 2021 Feb 12.
DOI: 10.1038/s41467-021-21129-z
Abstrakt: Systemic AA amyloidosis is a world-wide occurring protein misfolding disease of humans and animals. It arises from the formation of amyloid fibrils from serum amyloid A (SAA) protein. Using cryo electron microscopy we here show that amyloid fibrils which were purified from AA amyloidotic mice are structurally different from fibrils formed from recombinant SAA protein in vitro. Ex vivo amyloid fibrils consist of fibril proteins that contain more residues within their ordered parts and possess a higher β-sheet content than in vitro fibril proteins. They are also more resistant to proteolysis than their in vitro formed counterparts. These data suggest that pathogenic amyloid fibrils may originate from proteolytic selection, allowing specific fibril morphologies to proliferate and to cause damage to the surrounding tissue.
Databáze: MEDLINE